Tolvaptan and Conventional Treatment for Acute Decompensated Heart Failure
Not Applicable
- Conditions
- Acute decompensated heart failure
- Registration Number
- JPRN-UMIN000018081
- Lead Sponsor
- agano Matsushiro General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with hypersensitivity to Tolvaptan and the analogous compounds 2. Hemodialysis 3. Disability to appeal thirsty 4. Serum sodium > 145 mEq/L at allocation 5. Pregnancy 6. Acute coronary syndrome 7. Patients who attending physicians consider to be inappropriate due to other reasons mentioned above
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Defined length of hospital stay Occurrence rate of worsening renal function
- Secondary Outcome Measures
Name Time Method Event rate (cardiac death, readmission for heart failure) Urinary volume Dosage of Furosemide